CureVac N.V. ( CVAC) - Key Metrics
Stock symbol CVAC is outdated, potentially delisted? Maybe it is available on other exchange?
CVAC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | $0.01 | -$0.26 | -$0.19 | -$0.19 |
| 2025Q1 | $0 | -$0.23 | -$0.18 | -$0.19 |
| 2024Q4 | $0.06 | -$0.15 | -$0.30 | -$0.31 |
| 2024Q3 | $2.20 | $1.51 | $1.58 | $1.56 |
| 2024Q2 | $0.06 | -$0.32 | -$0.40 | -$0.43 |
CVAC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | -4.35 |
| 2025Q1 | ? | -2.77 |
| 2024Q4 | ? | -5.64 |
| 2024Q3 | ? | 0.44 |
| 2024Q2 | ? | -2.40 |
CVAC
Price: $4.66
52 week price:
Earnings Per Share: 0.67 USD
P/E Ratio: 6.97
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Germany
Volume: 537100
Market Capitalization: 1.1 billion